Questions & Answers:

Suppositories are primarily made up of Calcium Disodium EDTA and Cocoa Butter. It removes a wide range of toxic heavy metals including Mercury, Lead and Aluminum from the body. EDTA is a synthetic amino acid that has a binding ability to heavy metals and after it binds to a metal, it is excreted out of the body through the urine and feces.

 

EDTA, the active ingredient, is a synthetic amino acid that needs to remain whole to be effective. When taken by mouth, about 95% of the EDTA will be destroyed by the acids in the stomach making it unusable. Getting EDTA via an IV, while effective, is very time consuming, expensive and potentially dangerous due to the high dosage. With a suppository, there is about a 95% absorption rate and no requirement for blood work to determine kidney and liver function as is required before getting IV EDTA treatments.

 

 

What is EDTA?

EDTA is a widely-used abbreviation for the chemical compound ethylene diamine tetraacetic acid.

Are Toxic Heavy Metals a serious health problem?

Toxic heavy metals are one of the major causes, but under-reported causes, of many health problems we all face today. We come in contact with these metals on a daily basis though many sources including dental amalgams, cookware, deodorants, hair dyes, lipsticks, drinking water, metal food containers, the air we breathe, household cleaners etc. The only way to help combat this is to remove the toxic heavy metals from our bodies and to reduce or eliminate the contact points for these toxins.

 

It is strongly recommended that you supplement daily with a good quality, natural multi vitamin/mineral to help replace the needed minerals that are lost due to natural processes and chelation. The EDTA will bind with some essential minerals, but at a much slower rate than toxic heavy metals. Your body will breakdown and utilize essential minerals such as Iron, Zinc and Magnesium but not toxic heavy metals that it doesn't have any use for. Since the EDTA can only bind with what it finds we do not feel that it will deplete essential minerals from your body as long as you supplement on a regular basis. We recommend taking this mineral supplementation at least 8 hours separate from the chelation suppositories to give your body time to breakdown and utilize the minerals before the EDTA has a chance to bind with them.

 

By using a suppository you will get about 95% absorption of the EDTA, however with oral EDTA, only about 5% of the ingested EDTA will survive the stomach to be utilized. This makes oral EDTA therapy far less effective than the suppository method.

 

What is the Endothelium and how do Chelation Suppositories help?

 

Nitric oxide is a gas produced in the endothelium which controls the relaxing or dilating of the blood vessels. If nitric oxide is not produced, the blood vessels will become rigid and non-flexible causing hardening of the blood vessels. The EDTA in chelation suppositories will remove heavy metals from the endothelium helping it to produce nitric oxide thereby allowing the blood vessels to relax increasing the blood flow.

 

On the average, it will take between 80-120 minutes for the suppository to absorbed through the colon wall and directly into the blood stream. The time will vary due to many factors including body chemistry, matter build up etc.

 

Chelation suppositories use cocoa butter as the base which helps the suppository gently slide into the rectum with ease. There may be a slight bit of pressure due to the fact you are inserting a foreign object into your body, however your body will become accustomed to the process within the first few applications.

 

Chelation suppositories use calcium disodium EDTA, which has a neutral ph that will not irritate the colon.

 

 

 

What is Chelation Therapy?

The word "Chelation" comes from the Greek word "chele" which means a claw of a crab or lobster and implies a strong, pincer-like grasping. In the case of Chelation Therapy, the grasping is done by a chelating agent and the object grasped is a metal atom. This chelating agent forms a very stable chemical complex with a mineral or metal ion known as a "heterocyclic ring structure." There are many examples of chelates in nature such as magnesium in the chlorophyll molecule in plants, iron in the hemoglobin of blood cells in man and other higher organisms and the incorporation of cobalt in the vitamin B-12 molecule.

There are many "Chelating Agents" in nature such as vitamin C, sulphur-containing amino acids and many enzymes. Unless some of the enzymes contain a firmly bound metal atom they will not be active or have a decrease in their activity. Even the usual drugs used in medical practice in the treatment of disease are often dependent upon Chelation processes for their action. A new science has emerged which deals with the subject of Chelation and is know as Complexion or Bioinorganic Chemistry.1 The basis of this field is the inorganic chemical principles contained in and well explained by Ligand Field Theory. This theory deals with the mechanisms by which organic chemicals form three-dimensionally stable structures with metal ions through sharing of electrons. The resultant compounds are very stable and will only break apart with difficulty. A review of the science underlying Chelation Therapy may be found in a treatise by Bruce W. Halstead, M.D.2

 

 

In short, Chelation is a process whereby the metals are held and positioned by body chemicals so as to facilitate chemical reactions, which are essential to life. Chelation Therapy is the introduction of naturally occurring or synthetic organic chemicals into the human body in order to facilitate chemical reactions, which lead to the discharge of poisonous metals from the body and the rearrangement of essential metals in the body for the promotion of life's chemical reactions.

 

In the 1930s German chemists were searching for a compound which would bind calcium and other metals in order to prevent staining of printed-pattern linens with calcium from hard waters.

 

This basic research was being carried on independently in the United States by Frederick Bersworth who after much trial and error with different compounds finally patented EDTA.

 

In the late 1950s Dr. Clarke at Providence Hospital in Detroit in collaboration with Martin Rubin, PhD., Emeritus Professor of Chemistry at Georgetown University, began using EDTA intravenously to remove lead from people who had been poisoned in the automotive and other industries. He noted that indeed people with high lead levels in the circulation and their tissues began to excrete large amounts of lead in the urine after the administration of EDTA and began to feel better when the lead burden was removed. Coincidentally, the older patients who had arteriosclerosis involving the brain, heart, and peripheral vessels began to experience an improvement of their symptoms related to arteriosclerosis. There was an improvement in their angina, exercise tolerance and in their symptoms of Cerebrovascular insufficiency.^3-6

 

A number of American physicians who had been given no hope by their own M.D.s for various circulatory conditions began to undergo Chelation Therapy in Dr. Clarke's office. They usually improved and then went back to their own towns and began giving this treatment to their own patients.

 

What is Chelation Therapy Used For?

Chelation Therapy is used as the primary treatment for heavy metal intoxication by lead, cadmium, aluminum, mercury, arsenic, and even iron.^7-9 At this time, it is also used to treat occlusive vascular diseases in conjunction with diet, nutritional supplements, and lifestyle changes. Because Chelation Therapy appears to improve circulation and reduce toxic chemical reactions in the body, it has also been used successfully for arthritis, diabetes, high blood pressure, and eye diseases such as macular degeneration.

Can Chelation Be Used as a Preventive Measure?

 

It is often a good idea to undergo a series of Chelation treatments and maintenance therapy to prevent or delay the onset of vascular disease and the aging process.

 

This is especially important if there is a strong family history of these types of problems. Dr. Steven Davies of London, England has shown that heavy metals accumulate in human tissues throughout life and we can assume these poisons have deleterious effects on our health.

 

Evidence from a Swiss study indicated a reduced cancer incidence in patients who were chelated preventively.¹⁸

 

How Does Chelation Work?

Numerous theories have been erected to explain the obvious benefits of Chelation Therapy. The following is a list of possible mechanisms, all of which have been partially proven by research studies.

 

1) Heavy metals such as Lead, Mercury, Cadmium, Arsenic, Nickel, and Antimony have been shown to relentlessly accumulate in human tissue over a lifetime. Aluminum has been implicated as a possible factor in the causation of Alzheimer's disease. These poisonous metals disrupt the normal biochemical processes. They insinuate themselves into the active sites of enzymes thereby altering such enzymes' activities, and they initiate "free radical reactions," which produce noxious chemicals that damage cellular structures such as proteins, cell membranes and DNA. The results at the level of the whole organism are the development of degenerative diseases-arteriosclerosis, arthritis and cancers. The removal of these poison metals with Chelation Therapy is probably a major mechanism by which Chelation normalizes biochemical activity thereby improving circulation and energy.

 

2) Essential metals such as iron, copper, manganese, and zinc are rearranged in the various body compartments resulting in improved enzyme activity at the cellular level

 

3) Calcium deposits are removed from vessels and intracellular membranes leading to increased blood flow and better functioning of the enzyme systems imbedded in those membranes. The result is, again, improved organ function, vitality and energy level.

 

4) The blood clotting elements known as platelets are made less sticky, reducing clots in the vessels and leading to improved circulation and reduction in the thromboses that occur during heart attacks and strokes.

 

5) EDTA binds trace elements like iron, which are known initiators of "free radical reactions". These free radical reactions are thought to be the chemical origin of arteriosclerosis, cancer, and inflammations. In general, they are thought to be the cause of aging and its concomitant degenerative processes. With respect to #3 above, realize that a slight increase in the internal diameter of an occluded vessel results in a large increase in blood flow through that artery.

 

In fact, doubling the vessel's diameter results in a 16 to 32–fold increase in blood flow. If even a 10% increase in diameter occurs, there is still 1 l/2 to 3 times the blood flow. Therefore, a vessel doesn't need to be completely unclogged in order for the patient to experience a reduction in his symptoms.

 

The positive effects of EDTA Chelation Therapy are probably dependent both on decreasing the blood vessel occlusion and on the cellular and subcellular level effects of this agent. There are also probably many other unknown mechanisms.

 

Have Scientific Studies Shown That Chelation Therapy Is Effective?

If you call the American Medical Association or ask your cardiologist if Chelation Therapy can help arteriosclerosis chances are they will report that no studies have been done to document effectiveness of this treatment. In fact, studies proving effectiveness of EDTA in removing calcium deposits from tissues and reducing chest pain in heart patients date back to the 1960s.^21-39

 

Unfortunately, in the early years excessive doses of EDTA were used and adverse reactions followed. No nutritional support was given during therapy at that time and treatments were given on a daily basis, five or six days per week. As a result of the publication of a very few reports of poor results with Chelation the interest in treatment waned for a time. However, because of the dramatic improvement in so many patients, doctors continued to give the Therapy.

 

By the beginning of the 1970s, a professional organization of Chelation therapists was founded known today as The American College for Advancement in Medicine. Doctors from that group began to publish their findings.

 

H. Richard Casdorph, M.D., PhD. Published two articles in 1981. The first one documented an increase in left heart function immediately after a Chelation treatment using a radionuclide scan. The second study, again using a nuclear scan for measurements, revealed a highly significant increase in blood flow to the brain in a group of 15 patients after an average of 20 Chelation treatments.²² All 15 patients also had improvement in their symptoms.

 

A study done by Drs. McDonagh, Rudolph and Cheraskin in 1982 revealed a definite increase in blood flow to the brain using measurements of blood flow to the eyes.25 This study helps us to understand why Chelation Therapy often improves vision. These authors did two more studies in 1982²⁵ and 1983²⁶ showing improvement in kidney function using Chelation Therapy. This is contrary to the often-repeated claim by opponents of Chelation Therapy, that EDTA is dangerous to the kidneys. As long as the treatment is given slowly and in the recommended dosage even patients with moderate kidney dysfunction can be helped.

 

Drs. Casdorph and Farr published a report in 1983 of four patients with gangrene of the lower extremities who were treated with Chelation Therapy, nutritional supplements and hyperbaric oxygen.²⁷ All four patients had been told to undergo amputations by other doctors and sought an alternative in EDTA Chelation. All four patients were successful in avoiding amputation and follow up more than a year later revealed all patients to be doing well and free of pain in their legs. McDonagh et al published another study in 1985²⁸ on 77 elderly patients with documented occlusive vascular disease of the lower extremities. After 60 days of treatment, Doppler Ultrasound blood pressure measurements revealed a highly significant improvement in blood flow to the feet.

 

Studies by Dr. Van der Schaar in Holland and Dr. Kindness here in the U.S. were reported at the third International Chelation Conference at Georgetown University in Washington D.C. in July 1989.²⁹ Both studies revealed that EDTA infusion changes the "stickiness" of clotting factors in the blood known as platelets. This then results in a decrease in clot formation. Clot formation is thought to be the mechanism of various inflammatory disorders as well as heart attacks and strokes. Dr. Van der Schaar was a busy cardiovascular surgeon until 1985 when he began to experiment with Chelation Therapy. He has Chelated thousands of patients and only rarely does bypass surgery anymore.

 

Brazilian doctor, G.P. Deucher, published an article in 1987 documenting increased discharge of heavy metals such as iron in the urine after infusion of EDTA This finding correlated with a decrease in cardiovascular symptoms.

 

In 1985, I published a study done with Drs. John Bederka and Simca Brudno revealing large increases in aluminum output in the urine after infusion of EDTA³¹ Many researchers believe that accumulation of aluminum in the brain may be at least partially responsible for premature senility (Alzheimer's disease).

 

In 1989, Efrain Olszewer, M.D. and James P. Carter, M.D., DrPh published a retrospective study of 2,870 patients who had undergone Chelation Therapy in Brazil.

 

Patient response was evaluated by Doppler blood flow studies, EEG, motor and sensory tests, cognitive evaluation and memory tests. Overall, 68.8% of the patients had a "marked improvement", while 20.4% had a "good improvement" as defined in the study. This represented an overall improvement of 91.2%. Patients with heart or peripheral vessel disease fared better than those with carotid or cerebro-vascular obstruction.³⁴

 

Drs. Rudolph and McDonagh treated 31 patients with Chelation Therapy for arteriosclerosis of the carotid arteries and published their results in 1991. Evaluation of the degree of obstruction in the subjects' carotid vessels was performed before and after 30 infusions of EDTA using a Doppler ultrasound scanner. Overall intra-arterial obstruction decreased an average of 21%. This was highly statistically significant at p³⁴

 

A study of 470 patients in Denmark was published in 1993 by Drs. C. Hancke and K. Flytlie. In this study 80 to 91% improvement was documented depending on the measurement used. Of special interest: 92 of these patients had been initially referred for surgery (27 for leg amputations and 65 for coronary bypass) but after undergoing Chelation Therapy only 10 of this group had to undergo surgery. (Only 3 had amputations and 7 went to bypass surgery.) This saved 24 legs, 58 open-chest surgeries and $3,000,000 of insurance money in Denmark.³⁵

 

In 1994, Drs. Rudolph, Samuels, and McDonagh reported a dramatic improvement in a 59-year-old woman's visual fields after 30 Chelation treatments. This patient had been diagnosed with Map-Dot-Fingerprint dystrophy, a form of macular degeneration. Concomitantly her visual acuity was restored to normal after the treatments and 1-year follow-up revealed no relapse.³⁶

Even studies that purport to prove that Chelation Therapy isn't effective, when carefully analyzed, reveal the efficacy of EDTA The study of Van Rij showed that 60% of patients with very severe peripheral vascular disease in fact improved after 20 infusions of EDTA And, in this study, the EDTA group was compared to a "placebo" group that in fact received thiamine, vitamin C and magnesium. This was not in fact a placebo and only serves to prove that the vitamins and minerals we routinely add to the Chelation solution in fact are also efficacious in improving circulation!³⁷

 

Dr. H.J. Holliday, a vascular surgeon, published a case study in 1996 of a patient with recurrent carotid stenosis after an endarterectomy operation that he then chelated with EDTA This patient presented with an 80-85% stenosis of the right internal carotid artery and underwent an operation to remove the plaque. However, 2 years later the obstruction recurred to 65-70% and in 6 more months it had progressed to 70-75% again. The patient elected to undergo chelation therapy instead of another operation and after 20 chelation treatments the stenosis was reduced to 60-65% with a concomitant decrease in peak velocities with Doppler indicating an improvement in the hemodynamics at the site of obstruction. Dr. Holliday concluded that "EDTA chelation provides an exciting approach ... that reduces the degree of blockage".³⁸

 

Dr. Majid Ali and his associates published a study in which 26 consecutive patients with ischemic heart disease who had failed to respond to various combinations of by-pass surgery, angioplasty and multiple drug therapies were treated with 20 or more infusions of EDTA Some of these patients were assessed with Thallium Myocardial Perfusion Scans before and after their treatments. Of the 6 patients who underwent these scans 5 showed definite improvement in myocardial perfusion (more blood flowing to the heart muscle in areas previously lacking such flow). Overall clinical improvement as judged by relief of symptoms was as follows: 61% excellent, 17% good, 13% moderate and 9% poor. This is obviously far better results than can be expected from a placebo effect and there was no mortality (death) during the course of the study.³⁹

 

The question is always raised by patients and doctors alike: will Chelation Therapy unblock obstructed arteries? While there is no definitive proof at this time that is acceptable to the FDA, there are studies, which are highly suggestive that Chelation can do this. Drs. Rudolph and McDonagh treated a man with severe hypertension with a blockage to his left renal (kidney) artery. The patient underwent Chelation Therapy as an alternative to surgery. After 70 treatments there was a dramatic reduction of obstruction in the artery from 60-70% down to about 20% and his blood pressure normalized.⁴⁴

 

The American College for Advancement in Medicine is working with doctors and hospitals worldwide to sponsor studies to document EDTA Chelation therapy as a viable treatment for arteriosclerosis and other diseases of aging.

 

In time we believe EDTA Chelation Therapy will become an accepted, "standard" procedure in the practice of medicine.

 

One can access more information about and literature related to EDTA Chelation Therapy via the website of ACAM at http://www.acam.org/

 

 

KeLATOX and Detoxamin come with a 20 day unconditional guarantee. If for any reason you are not happy, simply return the product for a prompt full refund.